References A-G

ABERNETHY, A. P., CURROW, D. C., FRITH, P., FAZEKAS, B. S., MCHUGH, A. & BUI, C. (2003) Randomised, double blind, placebo controlled crossover trial of sustained release morphine for the management of refractory dyspnoea. BMJ, 327, 523-8.
ABERNETHY, A. P., MCDONALD, C. F., FRITH, P. A., CLARK, K., HERNDON, J. E., 2ND, MARCELLO, J., YOUNG, I. H., BULL, J., WILCOCK, A., BOOTH, S., WHEELER, J. L., TULSKY, J. A., CROCKETT, A. J. & CURROW, D. C. (2010) Effect of palliative oxygen versus room air in relief of breathlessness in patients with refractory dyspnoea: a double-blind, randomised controlled trial. Lancet, 376, 784-93.
ABRAMSON, M. J., SCHATTNER, R. L., SULAIMAN, N. D., BIRCH, K. E., SIMPSON, P. P., DEL COLLE, E. A., ARONI, R. A., WOLFE, R. & THIEN, F. C. (2010) Do spirometry and regular follow-up improve health outcomes in general practice patients with asthma or COPD? A cluster randomised controlled trial. Med J Aust, 193, 104-9.
ABUSAID, G. H., BARBAGELATA, A., TUERO, E., MAHMOOD, A. & SHARMA, G. (2009) Diastolic dysfunction and COPD exacerbation. Postgrad Med, 121, 76-81.
ACCESS ECONOMICS PTY LIMITED FOR THE AUSTRALIAN LUNG FOUNDATION (2008) Economic impact of COPD and cost-effective solutions.
ADABAG, A. S., WASSIF, H. S., RICE, K., MITHANI, S., JOHNSON, D., BONAWITZ-CONLIN, J., WARD, H. B., MCFALLS, E. O., KUSKOWSKI, M. A. & KELLY, R. F. (2010) Preoperative pulmonary function and mortality after cardiac surgery. Am Heart J, 159, 691-7.
ADAMS, S. G., SMITH, P. K., ALLAN, P. F., ANZUETO, A., PUGH, J. A. & CORNELL, J. E. (2007) Systematic review of the chronic care model in chronic obstructive pulmonary disease prevention and management. Arch Intern Med, 167, 551-61.
AFZAL, S., LANGE, P., BOJESEN, S. E., FREIBERG, J. J. & NORDESTGAARD, B. G. 2014. Plasma 25-hydroxyvitamin D, lung function and risk of chronic obstructive pulmonary disease. Thorax, 69, 24-31.
AGARWAL, S. K., HEISS, G., BARR, R. G., CHANG, P. P., LOEHR, L. R., CHAMBLESS, L. E., SHAHAR, E., KITZMAN, D. W. & ROSAMOND, W. D. (2012). Airflow obstruction, lung function, and risk of incident heart failure: the Atherosclerosis Risk in Communities (ARIC) study. Eur J Heart Fail, 14, 414-22.
AGLER, A. H., KURTH, T., GAZIANO, J. M., BURING, J. E. & CASSANO 2011. Randomised vitamin E supplementation and risk of chronic lung disease in the Women’s Health Study. Thorax, 66, 320-5.
AGUSTI, A., CALVERLEY, P. M., CELLI, B., COXSON, H. O., EDWARDS, L. D., LOMAS, D. A., MACNEE, W., MILLER, B. E., RENNARD, S., SILVERMAN, E. K., TAL-SINGER, R., WOUTERS, E., YATES, J. C., VESTBO, J. & EVALUATION OF, C. L. T. I. P. S. E. I. (2010). Characterisation of COPD heterogeneity in the ECLIPSE cohort. Respir Res, 11, 122.
AGUSTI, A., DE TERESA, L., DE BACKER, W., ZVARICH, M. T., LOCANTORE, N., BARNES, N., BOURBEAU, J. & CRIM, C. (2014). A comparison of the efficacy and safety of once-daily fluticasone furoate/vilanterol with twice-daily fluticasone propionate/salmeterol in moderate to very severe COPD. Eur Respir J, 43, 763-72.
AHMEDZAI, S., BALFOUR-LYNN, I. M., BEWICK, T., BUCHDAHL, R., COKER, R. K., CUMMIN, A. R., GRADWELL, D. P., HOWARD, L., INNES, J. A., JOHNSON, A. O., LIM, E., LIM, W. S., MCKINLAY, K. P., PARTRIDGE, M. R., POPPLESTONE, M., POZNIAK, A., ROBSON, A., SHOVLIN, C. L., SHRIKRISHNA, D., SIMONDS, A., TAIT, P. & THOMAS, M. (2011) Managing passengers with stable respiratory disease planning air travel: British Thoracic Society recommendations. Thorax, 66 Suppl 1, i1-30
AIHW & CANCER AUSTRALIA (2011). Lung cancer in Australia: an overview. Cancer series no. 64. Cat. no. CAN 58. Canberra: AIHW.
AL-GHIMLAS, F. & TODD, D. C. (2010) Creatine supplementation for patients with COPD receiving pulmonary rehabilitation: a systematic review and meta-analysis. Respirology, 15, 785-95.
ALBERT, R. K., CONNETT, J., BAILEY, W. C., CASABURI, R., COOPER, J. A., JR., CRINER, G. J., CURTIS, J. L., DRANSFIELD, M. T., HAN, M. K., LAZARUS, S. C., MAKE, B., MARCHETTI, N., MARTINEZ, F. J., MADINGER, N. E., MCEVOY, C., NIEWOEHNER, D. E., PORSASZ, J., PRICE, C. S., REILLY, J., SCANLON, P. D., SCIURBA, F. C., SCHARF, S. M., WASHKO, G. R., WOODRUFF, P. G. & ANTHONISEN, N. R. (2011) Azithromycin for prevention of exacerbations of COPD. N Engl J Med, 365, 689-98.
ALEVA, F. E., VOETS, L. W. L. M., SIMONS, S. O., DE MAST, Q., VAN DER VEN, A. J. A. M. & HEIJDRA, Y. F. 2017. Prevalence and Localization of Pulmonary Embolism in Unexplained Acute Exacerbations of COPD: A Systematic Review and Meta-analysis. Chest, 151, 544-554.
ALEXOPOULOS, G. S., KIOSSES, D. N., SIREY, J. A., KANELLOPOULOS, D., SEIRUP, J. K., NOVITCH, R. S., GHOSH, S., BANERJEE, S. & RAUE, P. J. (2014). Untangling therapeutic ingredients of a personalized intervention for patients with depression and severe COPD. Am J Geriatr Psychiatry, 22, 1316-24.
ALEXOPOULOS, G. S., SIREY, J. A., BANERJEE, S., KIOSSES, D. N., POLLARI, C., NOVITCH, R. S., ARTIS, A. & RAUE, P. J. (2016). Two Behavioral Interventions for Patients with Major Depression and Severe COPD. Am J Geriatr Psychiatry, 24, 964-974.
ALMAGRO, P., CABRERA, F. J., DIEZ, J., BOIXEDA, R., ALONSO ORTIZ, M. B., MURIO, C., SORIANO, J. B. & WORKING GROUP ON COPD, S. S. O. I. M. 2012. Comorbidities and short-term prognosis in patients hospitalized for acute exacerbation of COPD: the EPOC en Servicios de medicina interna (ESMI) study. Chest, 142, 1126-33.
ALMAGRO, P., SALVADO, M., GARCIA-VIDAL, C., RODRIGUEZ-CARBALLEIRA, M., DELGADO, M., BARREIRO, B., HEREDIA, J. L. & SORIANO, J. B. 2010. Recent improvement in long-term survival after a COPD hospitalisation. Thorax, 65, 298-302.
ALSHABANAT, A., ZAFARI, Z., ALBANYAN, O., DAIRI, M. & FITZGERALD, J. M. 2015. Asthma and COPD Overlap Syndrome (ACOS): A Systematic Review and Meta Analysis. PLoS One, 10, e0136065.
ALTENBURG, W. A., DE GREEF, M. H., TEN HACKEN, N. H. & WEMPE, J. B. (2012) A better response in exercise capacity after pulmonary rehabilitation in more severe COPD patients. Respir Med, 106, 694-700.
AMEER, F., CARSON, K. V., USMANI, Z. A. & SMITH, B. J. 2014. Ambulatory oxygen for people with chronic obstructive pulmonary disease who are not hypoxaemic at rest. Cochrane Database Syst Rev, 6, CD000238.
AMERICAN PSYCHIATRIC ASSOCIATION (2004) Diagnostic and Statistical Manual of Mental Disorders (DSM IV), American Psychiatric Association.
AMERICAN THORACIC SOCIETY (1995) Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. American Thoracic Society. Am J Respir Crit Care Med, 152, S77-121.
AMERICAN THORACIC SOCIETY/EUROPEAN RESPIRATORY SOCIETY (2003) American Thoracic Society/European Respiratory Society statement: standards for the diagnosis and management of individuals with alpha-1 antitrypsin deficiency. Am J Respir Crit Care Med, 168, 818-900.
ANDELL, P., KOUL, S., MARTINSSON, A., SUNDSTROM, J., JERNBERG, T., SMITH, J. G., JAMES, S., LINDAHL, B. & ERLINGE, D. 2014. Impact of chronic obstructive pulmonary disease on morbidity and mortality after myocardial infarction. Open Heart, 1, e000002.
ANSARI, Z., DUNT, D. & DHARMAGE, S. C. (2007) Variations in hospitalizations for chronic obstructive pulmonary disease in rural and urban Victoria, Australia. Respirology, 12, 874-80.
ANTHONISEN, N. R., CONNETT, J. E. & MURRAY, R. P. (2002) Smoking and lung function of Lung Health Study participants after 11 years. Am J Respir Crit Care Med, 166, 675-9.
ANTHONISEN, N. R., MANFREDA, J., WARREN, C. P., HERSHFIELD, E. S., HARDING, G. K. & NELSON, N. A. (1987) Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease. Ann Intern Med, 106, 196-204.
APPLETON, S., JONES, T., POOLE, P., PILOTTO, L., ADAMS, R., LASSERSON, T. J., SMITH, B. & MUHAMMAD, J. (2006a) Ipratropium bromide versus long-acting beta-2 agonists for stable chronic obstructive pulmonary disease. Cochrane Database Syst Rev, 3, CD006101.
APPLETON, S., POOLE, P., SMITH, B., VEALE, A., LASSERSON, T. J. & CHAN, M. M. (2006b) Long-acting beta2-agonists for poorly reversible chronic obstructive pulmonary disease. Cochrane Database Syst Rev, 3, CD001104.
ARCHER, S. L., MIKE, D., CROW, J., LONG, W. & WEIR, E. K. (1996) A placebo-controlled trial of prostacyclin in acute respiratory failure in COPD. Chest, 109, 750-5.
ARGYROPOULOU, P., PATAKAS, D., KOUKOU, A., VASILIADIS, P. & GEORGOPOULOS, D. (1993) Buspirone effect on breathlessness and exercise performance in patients with chronic obstructive pulmonary disease. Respiration, 60, 216-20.
ARYAL, S., DIAZ-GUZMAN, E. & MANNINO, D. M. 2014. Influence of sex on chronic obstructive pulmonary disease risk and treatment outcomes. Int J Chron Obstruct Pulmon Dis, 9, 1145-1154.
ATLANTIS, E., FAHEY, P., COCHRANE, B., WITTERT, G. & SMITH, S. (2013) Endogenous testosterone level and testosterone supplementation therapy in chronic obstructive pulmonary disease (COPD): a systematic review and meta-analysis. BMJ Open, 3.
AUBIER, M. (1988) Pharmacotherapy of respiratory muscles. Clin Chest Med, 9, 311-24.
AUBIN, H. J., BOBAK, A., BRITTON, J. R., ONCKEN, C., BILLING, C. B., JR., GONG, J., WILLIAMS, K. E. & REEVES, K. R. (2008) Varenicline versus transdermal nicotine patch for smoking cessation: results from a randomised open-label trial. Thorax, 63, 717-24.
AUSTIN, M. A., WILLS, K. E., BLIZZARD, L., WALTERS, E. H. & WOOD-BAKER, R. (2010) Effect of high flow oxygen on mortality in chronic obstructive pulmonary disease patients in prehospital setting: randomised controlled trial. BMJ, 341, c5462.
AUSTRALIAN BUREAU OF STATISTICS (2012) Australian Health Survey: First Results, 2011-12
AUSTRALIAN INSTITUTE OF HEALTH AND WELFARE (2008) Australia’s Health: : The eleventh biennial health report of the Australian Institute of Health and Welfare. 11th ed. Canberra, Australian Institute of Health and Welfare.
BADGETT, R. G., TANAKA, D. J., HUNT, D. K., JELLEY, M. J., FEINBERG, L. E., STEINER, J. F. & PETTY, T. L. (1993) Can moderate chronic obstructive pulmonary disease be diagnosed by historical and physical findings alone? Am J Med, 94, 188-96.
BAFADHEL, M., DAVIES, L., CALVERLEY, P. M., AARON, S. D., BRIGHTLING, C. E. & PAVORD, I. D. 2014. Blood eosinophil guided prednisolone therapy for exacerbations of COPD: a further analysis. Eur Respir J, 44, 789-91.
BAFADHEL, M., MCKENNA, S., TERRY, S., MISTRY, V., PANCHOLI, M., VENGE, P., LOMAS, D. A., BARER, M. R., JOHNSTON, S. L., PAVORD, I. D. & BRIGHTLING, C. E. 2012. Blood eosinophils to direct corticosteroid treatment of exacerbations of chronic obstructive pulmonary disease: a randomized placebo-controlled trial. Am J Respir Crit Care Med, 186, 48-55.
BALDI, S., AQUILANI, R., PINNA, G. D., POGGI, P., DE MARTINI, A. & BRUSCHI, C. (2010) Fat-free mass change after nutritional rehabilitation in weight losing COPD: role of insulin, C-reactive protein and tissue hypoxia. Int J Chron Obstruct Pulmon Dis, 5, 29-39.
BALDRICK, F. R., ELBORN, J. S., WOODSIDE, J. V., TREACY, K., BRADLEY, J. M., PATTERSON, C. C., SCHOCK, B. C., ENNIS, M., YOUNG, I. S. & MCKINLEY, M. C. (2012) Effect of fruit and vegetable intake on oxidative stress and inflammation in COPD: a randomised controlled trial. Eur Respir J, 39, 1377-84.
BARBERA, J. A., ROGER, N., ROCA, J., ROVIRA, I., HIGENBOTTAM, T. W. & RODRIGUEZ-ROISIN, R. (1996) Worsening of pulmonary gas exchange with nitric oxide inhalation in chronic obstructive pulmonary disease. Lancet, 347, 436-40.
BARNES, P. J. (2003) Theophylline: new perspectives for an old drug. Am J Respir Crit Care Med, 167, 813-8.
BARNES, P. J. & CELLI, B. R. 2009. Systemic manifestations and comorbidities of COPD. Eur Respir J, 33, 1165-85.
BARR, R. G., BLUEMKE, D. A., AHMED, F. S., CARR, J. J., ENRIGHT, P. L., HOFFMAN, E. A., JIANG, R., KAWUT, S. M., KRONMAL, R. A., LIMA, J. A., SHAHAR, E., SMITH, L. J. & WATSON, K. E. (2010) Percent emphysema, airflow obstruction, and impaired left ventricular filling. N Engl J Med, 362, 217-27.
BARR, R. G., BOURBEAU, J., CAMARGO, C. A. & RAM, F. S. (2005) Tiotropium for stable chronic obstructive pulmonary disease. Cochrane Database Syst Rev, CD002876.
BARR, R. G., BOURBEAU, J., CAMARGO, C. A. & RAM, F. S. (2006) Tiotropium for stable chronic obstructive pulmonary disease: A meta-analysis. Thorax, 61, 854-62.
BARTLETT, Y. K., SHEERAN, P. & HAWLEY, M. S. 2014. Effective behaviour change techniques in smoking cessation interventions for people with chronic obstructive pulmonary disease: a meta-analysis. Br J Health Psychol, 19, 181-203.
BATEMAN, E. D., CHAPMAN, K. R., SINGH, D., D’URZO, A. D., MOLINS, E., LESELBAUM, A. & GIL, E. G. 2015. Aclidinium bromide and formoterol fumarate as a fixed-dose combination in COPD: pooled analysis of symptoms and exacerbations from two six-month, multicentre, randomised studies (ACLIFORM and AUGMENT). Respir Res, 16, 92.
BATEMAN, E. D., FERGUSON, G. T., BARNES, N., GALLAGHER, N., GREEN, Y., HENLEY, M. & BANERJI, D. 2013. Dual bronchodilation with QVA149 versus single bronchodilator therapy: the SHINE study. Eur Respir J, 42, 1484-94.
BEASLEY, R., CHIEN, J., DOUGLAS, J., EASTLAKE, L., FARAH, C., KING, G., MOORE, R., PILCHER, J., RICHARDS, M., SMITH, S. & WALTERS, H. 2015. Thoracic Society of Australia and New Zealand oxygen guidelines for acute oxygen use in adults: ‘Swimming between the flags’. Respirology, 20, 1182-91.
BEAUCHAMP, M. K., HILL, K., GOLDSTEIN, R. S., JANAUDIS-FERREIRA, T. & BROOKS, D. 2009. Impairments in balance discriminate fallers from non-fallers in COPD. Respir Med, 103, 1885-91.
BEAUCHAMP, M. K., JANAUDIS-FERREIRA, T., PARREIRA, V., ROMANO, J. M., WOON, L., GOLDSTEIN, R. S. & BROOKS, D. 2013. A randomized controlled trial of balance training during pulmonary rehabilitation for individuals with COPD. Chest, 144, 1803-10.
BEAUCHAMP, M. K., SIBLEY, K. M., LAKHANI, B., ROMANO, J., MATHUR, S., GOLDSTEIN, R. S. & BROOKS, D. 2012. Impairments in systems underlying control of balance in COPD. Chest, 141, 1496-503.
BEEH, K. M., WESTERMAN, J., KIRSTEN, A. M., HEBERT, J., GRONKE, L., HAMILTON, A., TETZLAFF, K. & DEROM, E. 2015. The 24-h lung-function profile of once-daily tiotropium and olodaterol fixed-dose combination in chronic obstructive pulmonary disease. Pulm Pharmacol Ther, 32, 53-9.
BELMAN, M. J., BOTNICK, W. C. & SHIN, J. W. (1996) Inhaled bronchodilators reduce dynamic hyperinflation during exercise in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med, 153, 967-75.
BENDITT, J. O. & ALBERT, R. K. (1997) Surgical options for patients with advanced emphysema. Clin Chest Med, 18, 577-93.
BENEY, J., BERO, L. A. & BOND, C. (2000) Expanding the roles of outpatient pharmacists: effects on health services utilisation, costs, and patient outcomes. Cochrane Database Syst Rev, CD000336.
BENZO, R., FARRELL, M. H., CHANG, C. C., MARTINEZ, F. J., KAPLAN, R., REILLY, J., CRINER, G., WISE, R., MAKE, B., LUKETICH, J., FISHMAN, A. P. & SCIURBA, F. C. (2009) Integrating health status and survival data: the palliative effect of lung volume reduction surgery. Am J Respir Crit Care Med, 180, 239-46.
BERGER, R. & SMITH, D. (1988) Effect of inhaled metaproterenol on exercise performance in patients with stable “fixed” airway obstruction. Am Rev Respir Dis, 138, 624-9.
BERRY, S. D. & MILLER, R. R. 2008. Falls: epidemiology, pathophysiology, and relationship to fracture. Curr Osteoporos Rep, 6, 149-54.
BHATT, S. P., KIM, Y. I., WELLS, J. M., BAILEY, W. C., RAMSDELL, J. W., FOREMAN, M. G., JENSEN, R. L., STINSON, D. S., WILSON, C. G., LYNCH, D. A., MAKE, B. J. & DRANSFIELD, M. T. (2014a) FEV(1)/FEV(6) to diagnose airflow obstruction. Comparisons with computed tomography and morbidity indices. Ann Am Thorac Soc, 11, 335-41.
BHATT, S. P., NANDA, S. & KINTZER, J. S. (2012) Arrhythmias as trigger for acute exacerbations of chronic obstructive pulmonary disease. Respir Med, 106, 1134-8.
BHATT, S. P., SIEREN, J. C., DRANSFIELD, M. T., WASHKO, G. R., NEWELL, J. D., JR., STINSON, D. S., ZAMBA, G. K. & HOFFMAN, E. A. 2014b. Comparison of spirometric thresholds in diagnosing smoking-related airflow obstruction. Thorax, 69, 409-14.
BIERUT, L. J. (2010) Convergence of genetic findings for nicotine dependence and smoking related diseases with chromosome 15q24-25. Trends Pharmacol Sci, 31, 46-51
BISCHOFF, E. W., AKKERMANS, R., BOURBEAU, J., VAN WEEL, C., VERCOULEN, J. H. & SCHERMER, T. R. (2012) Comprehensive self management and routine monitoring in chronic obstructive pulmonary disease patients in general practice: randomised controlled trial. BMJ, 345, e7642.
BISELLI, P. J., KIRKNESS, J. P., GROTE, L., FRICKE, K., SCHWARTZ, A. R., SMITH, P. & SCHNEIDER, H. 2017. Nasal high-flow therapy reduces work of breathing compared with oxygen during sleep in COPD and smoking controls: a prospective observational study. J Appl Physiol (1985), 122, 82-88.
BLACKSTOCK, F. & WEBSTER, K. (2007) Disease-specific health education for COPD: a systematic review of changes in health outcomes. Health Educ Res, 22, 703-17.
BLACKSTOCK, F. C., WEBSTER, K. E., MCDONALD, C. F. & HILL, C. J. 2014. Comparable improvements achieved in chronic obstructive pulmonary disease through pulmonary rehabilitation with and without a structured educational intervention: a randomized controlled trial. Respirology, 19, 193-202.
BLAKEMORE, A., DICKENS, C., GUTHRIE, E., BOWER, P., KONTOPANTELIS, E., AFZAL, C. & COVENTRY, P. A. 2014. Depression and anxiety predict health-related quality of life in chronic obstructive pulmonary disease: systematic review and meta-analysis. Int J Chron Obstruct Pulmon Dis, 9, 501-12.
BLANC, P. D., IRIBARREN, C., TRUPIN, L., EARNEST, G., KATZ, P. P., BALMES, J., SIDNEY, S. & EISNER, M. D. (2009) Occupational exposures and the risk of COPD: dusty trades revisited. Thorax, 64, 6-12.
BLANCO, I., DE SERRES, F. J., FERNANDEZ-BUSTILLO, E., LARA, B. & MIRAVITLLES, M. (2006) Estimated numbers and prevalence of PI*S and PI*Z alleles of alpha1-antitrypsin deficiency in European countries. Eur Respir J, 27, 77-84.
BOLTON, C. E., BEVAN-SMITH, E. F., BLAKEY, J. D., CROWE, P., ELKIN, S. L., GARROD, R., GREENING, N. J., HESLOP, K., HULL, J. H., MAN, W. D., MORGAN, M. D., PROUD, D., ROBERTS, C. M., SEWELL, L., SINGH, S. J., WALKER, P. P., WALMSLEY, S., BRITISH THORACIC SOCIETY PULMONARY REHABILITATION GUIDELINE DEVELOPMENT, G. & BRITISH THORACIC SOCIETY STANDARDS OF CARE, C. 2013. British Thoracic Society guideline on pulmonary rehabilitation in adults. Thorax, 68 Suppl 2, ii1-30.
BOLTON, C. E., WATERS, C. S., PEIRCE, S. & ELWYN, G. (2011) Insufficient evidence of benefit: a systematic review of home telemonitoring for COPD. J Eval Clin Pract, 17, 1216-22.
BONTEN, M. J., HUIJTS, S. M., BOLKENBAAS, M., WEBBER, C., PATTERSON, S., GAULT, S., VAN WERKHOVEN, C. H., VAN DEURSEN, A. M., SANDERS, E. A., VERHEIJ, T. J., PATTON, M., MCDONOUGH, A., MORADOGHLI-HAFTVANI, A., SMITH, H., MELLELIEU, T., PRIDE, M. W., CROWTHER, G., SCHMOELE-THOMA, B., SCOTT, D. A., JANSEN, K. U., LOBATTO, R., OOSTERMAN, B., VISSER, N., CASPERS, E., SMORENBURG, A., EMINI, E. A., GRUBER, W. C. & GROBBEE, D. E. 2015. Polysaccharide conjugate vaccine against pneumococcal pneumonia in adults. N Engl J Med, 372, 1114-25.
BORGHI-SILVA, A., BALDISSERA, V., SAMPAIO, L. M., PIRES-DILORENZO, V. A., JAMAMI, M., DEMONTE, A., MARCHINI, J. S. & COSTA, D. (2006) L-carnitine as an ergogenic aid for patients with chronic obstructive pulmonary disease submitted to whole-body and respiratory muscle training programs. Braz J Med Biol Res, 39, 465-74.
BORRILL, Z., HOUGHTON, C., SULLIVAN, P. J. & SESTINI, P. (2003) Retrospective analysis of evidence base for tests used in diagnosis and monitoring of disease in respiratory medicine. BMJ, 327, 1136-8.
BOSNIC-ANTICEVICH, S., CHRYSTYN, H., COSTELLO, R. W., DOLOVICH, M. B., FLETCHER, M. J., LAVORINI, F., RODRIGUEZ-ROISIN, R., RYAN, D., WAN YAU MING, S. & PRICE, D. B. 2017. The use of multiple respiratory inhalers requiring different inhalation techniques has an adverse effect on COPD outcomes. Int J Chron Obstruct Pulmon Dis, 12, 59-71.
BOTT, J., CARROLL, M. P., CONWAY, J. H., KEILTY, S. E., WARD, E. M., BROWN, A. M., PAUL, E. A., ELLIOTT, M. W., GODFREY, R. C., WEDZICHA, J. A. & ET AL. (1993) Randomised controlled trial of nasal ventilation in acute ventilatory failure due to chronic obstructive airways disease. Lancet, 341, 1555-7.
BOUDESTEIN, L. C., RUTTEN, F. H., CRAMER, M. J., LAMMERS, J. W. & HOES, A. W. (2009) The impact of concurrent heart failure on prognosis in patients with chronic obstructive pulmonary disease. Eur J Heart Fail, 11, 1182-8.
BOUTOU, A. K., KARRAR, S., HOPKINSON, N. S. & POLKEY, M. I. 2013. Anemia and survival in chronic obstructive pulmonary disease: a dichotomous rather than a continuous predictor. Respiration, 85, 126-31.
BOUTOU, A. K., PITSIOU, G. G., STANOPOULOS, I., KONTAKIOTIS, T., KYRIAZIS, G. & ARGYROPOULOU, P. 2012. Levels of inflammatory mediators in chronic obstructive pulmonary disease patients with anemia of chronic disease: a case-control study. QJM, 105, 657-63.
BOUTOU, A. K., STANOPOULOS, I., PITSIOU, G. G., KONTAKIOTIS, T., KYRIAZIS, G., SICHLETIDIS, L. & ARGYROPOULOU, P. 2011. Anemia of chronic disease in chronic obstructive pulmonary disease: a case-control study of cardiopulmonary exercise responses. Respiration, 82, 237-45.
BOVE, D. G., LOMBORG, K., JENSEN, A. K., OVERGAARD, D., LINDHARDT, B. O. & MIDTGAARD, J. 2016. Efficacy of a minimal home-based psychoeducative intervention in patients with advanced COPD: A randomised controlled trial. Respir Med, 121, 109-116RADLEY, J. M., LASSERSON, T., ELBORN, S., MACMAHON, J. & O’NEILL, B. (2007) A systematic review of randomized controlled trials examining the short-term benefit of ambulatory oxygen in COPD. Chest, 131, 278-85.
BRADLEY, J. M., LASSERSON, T., ELBORN, S., MACMAHON, J. & O’NEILL, B. (2007) A systematic review of randomized controlled trials examining the short-term benefit of ambulatory oxygen in COPD. Chest, 131, 278-85.
BRADLEY, J. M. & O’NEILL, B. (2005) Short term ambulatory oxygen for chronic obstructive pulmonary disease. Cochrane Database Syst Rev, CD004356.
BRAIDO, F., BAIARDINI, I., CAZZOLA, M., BRUSSELLE, G., MARUGO, F. & CANONICA, G. W. (2013) Long-acting bronchodilators improve health related quality of life in patients with COPD. Respir Med, 107, 1465-80.
BRITISH THORACIC SOCIETY (1997) BTS guidelines for the management of chronic obstructive pulmonary disease. Thorax, 52, S1-S28.
BRITISH THORACIC SOCIETY (2008a) British Guideline on the Management of Asthma. Thorax, 63 Suppl 4, iv1-121.
BRITISH THORACIC SOCIETY (2008b) BTS statement on criteria for specialist referral, admission, discharge and follow-up for adults with respiratory disease. Thorax, 63 Suppl 1, i1-i16.
BROCHARD, L., MANCEBO, J., WYSOCKI, M., LOFASO, F., CONTI, G., RAUSS, A., SIMONNEAU, G., BENITO, S., GASPARETTO, A., LEMAIRE, F. & ET AL. (1995) Noninvasive ventilation for acute exacerbations of chronic obstructive pulmonary disease. N Engl J Med, 333, 817-22.
BROEKHUIZEN, R., WOUTERS, E. F., CREUTZBERG, E. C., WELING-SCHEEPERS, C. A. & SCHOLS, A. M. (2005) Polyunsaturated fatty acids improve exercise capacity in chronic obstructive pulmonary disease. Thorax, 60, 376-82.
BROOKS, D., KRIP, B., MANGOVSKI-ALZAMORA, S. & GOLDSTEIN, R. S. (2002) The effect of postrehabilitation programmes among individuals with chronic obstructive pulmonary disease. Eur Respir J, 20, 20-9.
BRUNELLI, A., KIM, A. W., BERGER, K. I. & ADDRIZZO-HARRIS, D. J. 2013. Physiologic evaluation of the patient with lung cancer being considered for resectional surgery: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest, 143, e166S-90S.
BRUSKE, I., THIERING, E., HEINRICH, J., HUSTER, K. M. & NOWAK, D. 2014. Respirable quartz dust exposure and airway obstruction: a systematic review and meta-analysis. Occup Environ Med, 71, 583-9.
BRUSSELLE, G., PRICE, D., GRUFFYDD-JONES, K., MIRAVITLLES, M., KEININGER, D. L., STEWART, R., BALDWIN, M. & JONES, R. C. 2015. The inevitable drift to triple therapy in COPD: an analysis of prescribing pathways in the UK. Int J Chron Obstruct Pulmon Dis, 10, 2207-17.
BRYANT, J., MCDONALD, V. M., BOYES, A., SANSON-FISHER, R., PAUL, C. & MELVILLE, J. (2013) Improving medication adherence in chronic obstructive pulmonary disease: a systematic review. Respir Res, 14, 109.
BUCKNALL, C. E., MILLER, G., LLOYD, S. M., CLELAND, J., MCCLUSKEY, S., COTTON, M., STEVENSON, R. D., COTTON, P. & MCCONNACHIE, A. (2012) Glasgow supported self-management trial (GSuST) for patients with moderate to severe COPD: randomised controlled trial. BMJ, 344, e1060.
BUHL, R., GESSNER, C., SCHUERMANN, W., FOERSTER, K., SIEDER, C., HILTL, S. & KORN, S. 2015a. Efficacy and safety of once-daily QVA149 compared with the free combination of once-daily tiotropium plus twice-daily formoterol in patients with moderate-to-severe COPD (QUANTIFY): a randomised, non-inferiority study. Thorax, 70, 311-9.
BUHL, R., MALTAIS, F., ABRAHAMS, R., BJERMER, L., DEROM, E., FERGUSON, G., FLEZAR, M., HEBERT, J., MCGARVEY, L., PIZZICHINI, E., REID, J., VEALE, A., GRONKE, L., HAMILTON, A., KORDUCKI, L., TETZLAFF, K., WAITERE-WIJKER, S., WATZ, H. & BATEMAN, E. 2015b. Tiotropium and olodaterol fixed-dose combination versus mono-components in COPD (GOLD 2-4). Eur Respir J, 45, 969-79.
BULA, C. J., WIETLISBACH, V., BURNAND, B. & YERSIN, B. (2001) Depressive symptoms as a predictor of 6-month outcomes and services utilization in elderly medical inpatients. Arch Intern Med, 161, 2609-15.
BULLEN, C., HOWE, C., LAUGESEN, M., MCROBBIE, H., PARAG, V., WILLIMAN, J. & WALKER, N. 2013. Electronic cigarettes for smoking cessation: a randomised controlled trial. Lancet, 382, 1629-37.
BURGEL, P. R., NESME-MEYER, P., CHANEZ, P., CAILLAUD, D., CARRE, P., PEREZ, T. & ROCHE, N. (2009) Cough and sputum production are associated with frequent exacerbations and hospitalizations in COPD subjects. Chest, 135, 975-82.
BURNS, K. E., MEADE, M. O., PREMJI, A. & ADHIKARI, N. K. 2013. Noninvasive positive-pressure ventilation as a weaning strategy for intubated adults with respiratory failure. Cochrane Database Syst Rev, 12, CD004127.
BURROWS, B., KNUDSON, R., CLINE, M. & LEBOWITZ, M. (1977) Quantitative relationships between cigarette smoking and ventilatory function. American Rev Respir Dis, 115, 195-205.
BURSI, F., VASSALLO, R., WESTON, S. A., KILLIAN, J. M. & ROGER, V. L. (2010) Chronic obstructive pulmonary disease after myocardial infarction in the community. Am Heart J, 160, 95-101.
BUSCH, R., HAN, M. K., BOWLER, R. P., DRANSFIELD, M. T., WELLS, J. M., REGAN, E. A. & HERSH, C. P. 2016. Risk factors for COPD exacerbations in inhaled medication users: the COPDGene study biannual longitudinal follow-up prospective cohort. BMC Pulm Med, 16, 28.
CAHILL, K., LANCASTER, T. & GREEN, N. 2010. Stage-based interventions for smoking cessation. Cochrane Database Syst Rev, CD004492.
CAHILL, K., STEAD, L. F. & LANCASTER, T. (2008) Nicotine receptor partial agonists for smoking cessation. Cochrane Database Syst Rev, CD006103.
CAHILL, K., STEVENS, S., PERERA, R. & LANCASTER, T. 2013. Pharmacological interventions for smoking cessation: an overview and network meta-analysis. Cochrane Database Syst Rev, 5, CD009329.
CALVERLEY, P. M., ANDERSON, J. A., CELLI, B., FERGUSON, G. T., JENKINS, C., JONES, P. W., CRIM, C., WILLITS, L. R., YATES, J. C. & VESTBO, J. 2010. Cardiovascular events in patients with COPD: TORCH study results. Thorax, 65, 719-25.
CALVERLEY, P. M., ANDERSON, J. A., CELLI, B., FERGUSON, G. T., JENKINS, C., JONES, P. W., YATES, J. C. & VESTBO, J. (2007) Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. N Engl J Med, 356, 775-89.
CALVERLEY, P. M., RABE, K. F., GOEHRING, U. M., KRISTIANSEN, S., FABBRI, L. M. & MARTINEZ, F. J. (2009) Roflumilast in symptomatic chronic obstructive pulmonary disease: two randomised clinical trials. Lancet, 374, 685-94.
CALVERLEY, P. M., STOCKLEY, R. A., SEEMUNGAL, T. A., HAGAN, G., WILLITS, L. R., RILEY, J. H. & WEDZICHA, J. A. (2011) Reported pneumonia in patients with COPD: findings from the INSPIRE study. Chest, 139, 505-12.
CALZETTA, L., ROGLIANI, P., ORA, J., PUXEDDU, E., CAZZOLA, M. & MATERA, M. G. 2017. LABA/LAMA combination in COPD: a meta-analysis on the duration of treatment. Eur Respir Rev, 26.
CAMP, P. G., COXSON, H. O., LEVY, R. D., PILLAI, S. G., ANDERSON, W., VESTBO, J., KENNEDY, S. M., SILVERMAN, E. K., LOMAS, D. A. & PARE, P. D. (2009) Sex differences in emphysema and airway disease in smokers. Chest, 136, 1480-8.
CANCER COUNCIL AUSTRALIA (2004) Clinical Practice Guidelines for the Prevention, Diagnosis and Management of Lung Cancer. Sydney.
CANNON, D., BUYS, N., SRIRAM, K. B., SHARMA, S., MORRIS, N. & SUN, J. 2016. The effects of chronic obstructive pulmonary disease self-management interventions on improvement of quality of life in COPD patients: A meta-analysis. Respir Med, 121, 81-90.
CAPONNETTO, P., CAMPAGNA, D., CIBELLA, F., MORJARIA, J. B., CARUSO, M., RUSSO, C. & POLOSA, R. 2013. EffiCiency and Safety of an eLectronic cigAreTte (ECLAT) as tobacco cigarettes substitute: a prospective 12-month randomized control design study. PLoS One, 8, e66317.
CARR, A. B. & EBBERT, J. 2012. Interventions for tobacco cessation in the dental setting. Cochrane Database Syst Rev, 6, CD005084.
CASANOVA, C., COTE, C., DE TORRES, J. P., AGUIRRE-JAIME, A., MARIN, J. M., PINTO-PLATA, V. & CELLI, B. R. (2005) Inspiratory-to-total lung capacity ratio predicts mortality in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med, 171, 591-7.
CASAS, A., TROOSTERS, T., GARCIA-AYMERICH, J., ROCA, J., HERNANDEZ, C., ALONSO, A., DEL POZO, F., DE TOLEDO, P., ANTO, J. M., RODRIGUEZ-ROISIN, R. & DECRAMER, M. (2006) Integrated care prevents hospitalisations for exacerbations in COPD patients. Eur Respir J, 28, 123-30.
CATES, C. J., CRILLY, J. A. & ROWE, B. H. (2006) Holding chambers (spacers) versus nebulisers for beta-agonist treatment of acute asthma. Cochrane Database Syst Rev, CD000052.
CAVALHERI, V., STRAKER, L., GUCCIARDI, D. F., GARDINER, P. A. & HILL, K. 2016. Changing physical activity and sedentary behaviour in people with COPD. Respirology, 21, 419-26.
CAZZOLA, M., CALZETTA, L., PAGE, C., JARDIM, J., CHUCHALIN, A. G., ROGLIANI, P. & MATERA, M. G. 2015a. Influence of N-acetylcysteine on chronic bronchitis or COPD exacerbations: a meta-analysis. Eur Respir Rev, 24, 451-61.
CAZZOLA, M., HANANIA, N. A., MACNEE, W., RUDELL, K., HACKFORD, C. & TAMIMI, N. 2015b. A review of the most common patient-reported outcomes in COPD–revisiting current knowledge and estimating future challenges. Int J Chron Obstruct Pulmon Dis, 10, 725-38.
CECERE, L. M., LITTMAN, A. J., SLATORE, C. G., UDRIS, E. M., BRYSON, C. L., BOYKO, E. J., PIERSON, D. J. & AU, D. H. (2011) Obesity and COPD: associated symptoms, health-related quality of life, and medication use. COPD, 8, 275-84.
CELLI, B., DECRAMER, M., KESTEN, S., LIU, D., MEHRA, S. & TASHKIN, D. P. (2009) Mortality in the 4-year trial of tiotropium (UPLIFT) in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med, 180, 948-55.
CELLI, B. R. (1995) Pulmonary rehabilitation in patients with COPD. Am J Respir Crit Care Med, 152, 861-4.
CELLI, B. R., COTE, C. G., LAREAU, S. C. & MEEK, P. M. (2008) Predictors of Survival in COPD: more than just the FEV1. Respir Med, 102 Suppl 1, S27-35.
CELLI, B. R., COTE, C. G., MARIN, J. M., CASANOVA, C., MONTES DE OCA, M., MENDEZ, R. A., PINTO PLATA, V. & CABRAL, H. J. (2004) The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med, 350, 1005-12.
CERVERI, I., CORSICO, A. G., ACCORDINI, S., NINIANO, R., ANSALDO, E., ANTO, J. M., KUNZLI, N., JANSON, C., SUNYER, J., JARVIS, D., SVANES, C., GISLASON, T., HEINRICH, J., SCHOUTEN, J. P., WJST, M., BURNEY, P. & DE MARCO, R. 2008. Underestimation of airflow obstruction among young adults using FEV1/FVC <70% as a fixed cut-off: a longitudinal evaluation of clinical and functional outcomes. Thorax, 63, 1040-5.
CHAMBELLAN, A., CHAILLEUX, E., SIMILOWSKI, T. & GROUP, A. O. 2005. Prognostic value of the hematocrit in patients with severe COPD receiving long-term oxygen therapy. Chest, 128, 1201-8.
CHANG, A. B., BELL, S. C., TORZILLO, P. J., KING, P. T., MAGUIRE, G. P., BYRNES, C. A., HOLLAND, A. E., O’MARA, P., GRIMWOOD, K. & EXTENDED VOTING, G. 2015. Chronic suppurative lung disease and bronchiectasis in children and adults in Australia and New Zealand Thoracic Society of Australia and New Zealand guidelines. Med J Aust, 202, 130.
CHANG, C. L., ROBINSON, S. C., MILLS, G. D., SULLIVAN, G. D., KARALUS, N. C., MCLACHLAN, J. D. & HANCOX, R. J. (2011) Biochemical markers of cardiac dysfunction predict mortality in acute exacerbations of COPD. Thorax, 66, 764-8.
CHAOUAT, A., BUGNET, A. S., KADAOUI, N., SCHOTT, R., ENACHE, I., DUCOLONE, A., EHRHART, M., KESSLER, R. & WEITZENBLUM, E. (2005) Severe pulmonary hypertension and chronic obstructive pulmonary disease. Am J Respir Crit Care Med, 172, 189-94.
CHAOUAT, A., NAEIJE, R. & WEITZENBLUM, E. (2008) Pulmonary hypertension in COPD. Eur Respir J, 32, 1371-85.
CHAOUAT, A., WEITZENBLUM, E., KRIEGER, J., IFOUNDZA, T., OSWALD, M. & KESSLER, R. (1995) Association of chronic obstructive pulmonary disease and sleep apnea syndrome. Am J Respir Crit Care Med, 151, 82-6.
CHAPMAN, K. R., BEEH, K. M., BEIER, J., BATEMAN, E. D., D’URZO, A., NUTBROWN, R., HENLEY, M., CHEN, H., OVEREND, T. & D’ANDREA, P. (2014) A blinded evaluation of the efficacy and safety of glycopyrronium, a once-daily long-acting muscarinic antagonist, versus tiotropium, in patients with COPD: the GLOW5 study. BMC Pulm Med, 14, 4.
CHAPMAN, K. R., BURDON, J. G., PIITULAINEN, E., SANDHAUS, R. A., SEERSHOLM, N., STOCKS, J. M., STOEL, B. C., HUANG, L., YAO, Z., EDELMAN, J. M., MCELVANEY, N. G. & GROUP, R. T. S. 2015. Intravenous augmentation treatment and lung density in severe alpha1 antitrypsin deficiency (RAPID): a randomised, double-blind, placebo-controlled trial. Lancet, 386, 360-8.
CHEN, D., RESTREPO, M. I., FINE, M. J., PUGH, M. J., ANZUETO, A., METERSKY, M. L., NAKASHIMA, B., GOOD, C. & MORTENSEN, E. M. (2011) Observational study of inhaled corticosteroids on outcomes for COPD patients with pneumonia. Am J Respir Crit Care Med, 184, 312-6.
CHEN, R. C., LI, X. Y., GUAN, L. L., GUO, B. P., WU, W. L., ZHOU, Z. Q., HUO, Y. T., CHEN, X. & ZHOU, L. Q. 2016. Effectiveness of neuromuscular electrical stimulation for the rehabilitation of moderate-to-severe COPD: a meta-analysis. Int J Chron Obstruct Pulmon Dis, 11, 2965-2975.
CHEN, W., THOMAS, J., SADATSAFAVI, M. & FITZGERALD, J. M. 2015. Risk of cardiovascular comorbidity in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis. Lancet Respir Med, 3, 631-9.
CHEYNE, L., IRVIN-SELLERS, MJ. & WHITE, J., (2015) Tiotropium versus ipratropium bromide for chronic obstructive pulmonary disease. Cochrane Database Syst Rev9, CD009552.
CHONG, J., KARNER, C. & POOLE, P. (2012) Tiotropium versus long-acting beta-agonists for stable chronic obstructive pulmonary disease. Cochrane Database Syst Rev9, CD009157.
CHONG, J., POOLE, P., LEUNG, B. & BLACK, P. N. (2013) Phosphodiesterase 4 inhibitors for chronic obstructive pulmonary disease. Cochrane Database Syst Rev, 11, CD002309.
CHOW, J. W., KHULLAR, K., KATECHIA, K., KLIM, S. & KELLY, A. M. 2016. Controlled oxygen therapy at emergency department presentation increases the likelihood of achieving target oxygen saturations in patients with exacerbations of chronic obstructive pulmonary disease. Emerg Med Australas, 28, 44-7.
CHRYSTYN, H., MULLEY, B. A. & PEAKE, M. D. (1988) Dose response relation to oral theophylline in severe chronic obstructive airways disease. BMJ, 297, 1506-10.
CHRYSTYN, H., VAN DER PALEN, J., SHARMA, R., BARNES, N., DELAFONT, B., MAHAJAN, A. & THOMAS, M. 2017. Device errors in asthma and COPD: systematic literature review and meta-analysis. NPJ Prim Care Respir Med, 27, 22.
CIVLJAK, M., STEAD, L. F., HARTMANN-BOYCE, J., SHEIKH, A. & CAR, J. 2013. Internet-based interventions for smoking cessation. Cochrane Database Syst Rev, 7, CD007078.
CLAESSENS, M. T., LYNN, J., ZHONG, Z., DESBIENS, N. A., PHILLIPS, R. S., WU, A. W., HARRELL, F. E., JR. & CONNORS, A. F., JR. (2000) Dying with lung cancer or chronic obstructive pulmonary disease: insights from SUPPORT. Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments. J Am Geriatr Soc, 48, S146-53.
COE, J. W., BROOKS, P. R., VETELINO, M. G., WIRTZ, M. C., ARNOLD, E. P., HUANG, J., SANDS, S. B., DAVIS, T. I., LEBEL, L. A., FOX, C. B., SHRIKHANDE, A., HEYM, J. H., SCHAEFFER, E., ROLLEMA, H., LU, Y., MANSBACH, R. S., CHAMBERS, L. K., ROVETTI, C. C., SCHULZ, D. W., TINGLEY, F. D., 3RD & O’NEILL, B. T. (2005) Varenicline: an alpha4beta2 nicotinic receptor partial agonist for smoking cessation. J Med Chem, 48, 3474-7.
COLLINS, P. F., ELIA, M., KURUKULAARATCHY, R. J. & STRATTON, R. J. 2016. The influence of deprivation on malnutrition risk in outpatients with chronic obstructive pulmonary disease (COPD). Clin Nutr.
COLLINS, P. F., ELIA, M. & STRATTON, R. J. 2013. Nutritional support and functional capacity in chronic obstructive pulmonary disease: a systematic review and meta-analysis. Respirology, 18, 616-29.
COLLINS, P. F., STRATTON, R. J. & ELIA, M. 2012. Nutritional support in chronic obstructive pulmonary disease: a systematic review and meta-analysis. Am J Clin Nutr, 95, 1385-95.
COME, C. E., KRAMER, M. R., DRANSFIELD, M. T., ABU-HIJLEH, M., BERKOWITZ, D., BEZZI, M., BHATT, S. P., BOYD, M. B., CASES, E., CHEN, A. C., COOPER, C. B., FLANDES, J., GILDEA, T., GOTFRIED, M., HOGARTH, D. K., KOLANDAIVELU, K., LEEDS, W., LIESCHING, T., MARCHETTI, N., MARQUETTE, C., MULARSKI, R. A., PINTO-PLATA, V. M., PRITCHETT, M. A., RAFEQ, S., RUBIO, E. R., SLEBOS, D. J., STRATAKOS, G., SY, A., TSAI, L. W., WAHIDI, M., WALSH, J., WELLS, J. M., WHITTEN, P. E., YUSEN, R., ZULUETA, J. J., CRINER, G. J. & WASHKO, G. R. 2015. A randomised trial of lung sealant versus medical therapy for advanced emphysema. Eur Respir J, 46, 651-62.
CONNORS, A. F., JR., DAWSON, N. V., THOMAS, C., HARRELL, F. E., JR., DESBIENS, N., FULKERSON, W. J., KUSSIN, P., BELLAMY, P., GOLDMAN, L. & KNAUS, W. A. (1996) Outcomes following acute exacerbation of severe chronic obstructive lung disease. The SUPPORT investigators (Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments) [published erratum appears in Am J Respir Crit Care Med 1997;155:386]. Am J Respir Crit Care Med, 154, 959-67.
COOPER, J. D., TRULOCK, E. P., TRIANTAFILLOU, A. N., PATTERSON, G. A., POHL, M. S., DELONEY, P. A., SUNDARESAN, R. S. & ROPER, C. L. (1995) Bilateral pneumectomy (volume reduction) for chronic obstructive pulmonary disease. J Thorac Cardiovasc Surg, 109, 106-16; discussion 116-9.
CORTI, C., FALLY, M., FABRICIUS-BJERRE, A., MORTENSEN, K., JENSEN, B. N., ANDREASSEN, H. F., PORSBJERG, C., KNUDSEN, J. D. & JENSEN, J. U. 2016. Point-of-care procalcitonin test to reduce antibiotic exposure in patients hospitalized with acute exacerbation of COPD. Int J Chron Obstruct Pulmon Dis, 11, 1381-9.
COSIO, B. G., IGLESIAS, A., RIOS, A., NOGUERA, A., SALA, E., ITO, K., BARNES, P. J. & AGUSTI, A. (2009) Low-dose theophylline enhances the anti-inflammatory effects of steroids during exacerbations of COPD. Thorax, 64, 424-9.
COTE, C., ZILBERBERG, M. D., MODY, S. H., DORDELLY, L. J. & CELLI, B. 2007a. Haemoglobin level and its clinical impact in a cohort of patients with COPD. Eur Respir J, 29, 923-9.
COTE, C. G., PINTO-PLATA, V., KASPRZYK, K., DORDELLY, L. J. & CELLI, B. R. 2007b. The 6-min walk distance, peak oxygen uptake, and mortality in COPD. Chest, 132, 1778-85.
COVENTRY, P. A., BOWER, P., KEYWORTH, C., KENNING, C., KNOPP, J., GARRETT, C., HIND, D., MALPASS, A. & DICKENS, C. (2013) The effect of complex interventions on depression and anxiety in chronic obstructive pulmonary disease: systematic review and meta-analysis. PLoS One, 8, e60532.
COVENTRY, P. A. & HIND, D. (2007) Comprehensive pulmonary rehabilitation for anxiety and depression in adults with chronic obstructive pulmonary disease: Systematic review and meta-analysis. J Psychosom Res, 63, 551-65.
CRANSTON, J. M., CROCKETT, A. J., MOSS, J. R. & ALPERS, J. H. (2005) Domiciliary oxygen for chronic obstructive pulmonary disease. Cochrane Database Syst Rev, CD001744.
CREWS, W. D., JEFFERSON, A. L., BOLDUC, T., ELLIOTT, J. B., FERRO, N. M., BROSHEK, D. K., BARTH, J. T. & ROBBINS, M. K. (2001) Neuropsychological dysfunction in patients suffering from end-stage chronic obstructive pulmonary disease. Arch Clin Neuropsychol, 16, 643-52.
CRIM, C., DRANSFIELD, M. T., BOURBEAU, J., JONES, P. W., HANANIA, N. A., MAHLER, D. A., VESTBO, J., WACHTEL, A., MARTINEZ, F. J., BARNHART, F., LETTIS, S. & CALVERLEY, P. M. 2015. Pneumonia risk with inhaled fluticasone furoate and vilanterol compared with vilanterol alone in patients with COPD. Ann Am Thorac Soc, 12, 27-34.
CRINER, G. J., CONNETT, J. E., AARON, S. D., ALBERT, R. K., BAILEY, W. C., CASABURI, R., COOPER, J. A., JR., CURTIS, J. L., DRANSFIELD, M. T., HAN, M. K., MAKE, B., MARCHETTI, N., MARTINEZ, F. J., NIEWOEHNER, D. E., SCANLON, P. D., SCIURBA, F. C., SCHARF, S. M., SIN, D. D., VOELKER, H., WASHKO, G. R., WOODRUFF, P. G. & LAZARUS, S. C. 2014. Simvastatin for the prevention of exacerbations in moderate-to-severe COPD. N Engl J Med, 370, 2201-10.
CRINER, G. J., CORDOVA, F., STERNBERG, A. L. & MARTINEZ, F. J. (2011) The National Emphysema Treatment Trial (NETT) Part II: Lessons learned about lung volume reduction surgery. Am J Respir Crit Care Med, 184, 881-93.
CUI, H., WEI, Z. M., FAN, L., ZHANG, M., LIU, L. & HU, Y. X. 2012. [Clinical predictive value of hemoglobin level in mortality of hospitalized COPD patients]. Zhongguo Ying Yong Sheng Li Xue Za Zhi, 28, 394-7.
CUI, L., GALLAGHER, L. G., RAY, R. M., LI, W., GAO, D., ZHANG, Y., VEDAL, S., THOMAS, D. B. & CHECKOWAY, H. (2011) Unexpected excessive chronic obstructive pulmonary disease mortality among female silk textile workers in Shanghai, China. Occup Environ Med, 68, 883-7.
D’URZO, A., FERGUSON, G. T., VAN NOORD, J. A., HIRATA, K., MARTIN, C., HORTON, R., LU, Y., BANERJI, D. & OVEREND, T. (2011) Efficacy and safety of once-daily NVA237 in patients with moderate-to-severe COPD: the GLOW1 trial. Respir Res, 12, 156.
D’URZO, A. D., RENNARD, S. I., KERWIN, E. M., MERGEL, V., LESELBAUM, A. R., CARACTA, C. F. & INVESTIGATORS, A. C. S. 2014. Efficacy and safety of fixed-dose combinations of aclidinium bromide/formoterol fumarate: the 24-week, randomized, placebo-controlled AUGMENT COPD study. Respir Res, 15, 123.
DAGA, M. K., CHHABRA, R., SHARMA, B. & MISHRA, T. K. (2003) Effects of exogenous vitamin E supplementation on the levels of oxidants and antioxidants in chronic obstructive pulmonary disease. J Biosci, 28, 7-11.
DAHL, R., CHAPMAN, K. R., RUDOLF, M., MEHTA, R., KHO, P., ALAGAPPAN, V. K., CHEN, H. & BANERJI, D. 2013. Safety and efficacy of dual bronchodilation with QVA149 in COPD patients: the ENLIGHTEN study. Respir Med, 107, 1558-67.
DAL NEGRO, R. W., AQUILANI, R., BERTACCO, S., BOSCHI, F., MICHELETTO, C. & TOGNELLA, S. (2010) Comprehensive effects of supplemented essential amino acids in patients with severe COPD and sarcopenia. Monaldi Arch Chest Dis, 73, 25-33.
DANIELS, J. M., SNIJDERS, D., DE GRAAFF, C. S., VLASPOLDER, F., JANSEN, H. M. & BOERSMA, W. G. (2010) Antibiotics in addition to systemic corticosteroids for acute exacerbations of chronic obstructive pulmonary disease. Am J Respir Crit Care Med, 181, 150-7.
DAVEY, C., ZOUMOT, Z., JORDAN, S., MCNULTY, W. H., CARR, D. H., HIND, M. D., HANSELL, D. M., RUBENS, M. B., BANYA, W., POLKEY, M. I., SHAH, P. L. & HOPKINSON, N. S. 2015. Bronchoscopic lung volume reduction with endobronchial valves for patients with heterogeneous emphysema and intact interlobar fissures (the BeLieVeR-HIFi study): a randomised controlled trial. Lancet, 386, 1066-73.
DAVIS, A. L., ARANDA, C. P., SCHIFFMAN, G. & CHRISTIANSON, L. C. (1987) Pneumococcal infection and immunologic response to pneumococcal vaccine in chronic obstructive pulmonary disease. A pilot study. Chest, 92, 204-12.
DE GODOY, D. V. & DE GODOY, R. F. (2003) A randomized controlled trial of the effect of psychotherapy on anxiety and depression in chronic obstructive pulmonary disease. Arch Phys Med Rehabil, 84, 1154-7.
DE MIGUEL-DIEZ, J., CARRASCO-GARRIDO, P., REJAS-GUTIERREZ, J., MARTIN-CENTENO, A., GOBARTT-VAZQUEZ, E., HERNANDEZ-BARRERA, V., DE MIGUEL, A. G. & JIMENEZ-GARCIA, R. (2010) The influence of heart disease on characteristics, quality of life, use of health resources, and costs of COPD in primary care settings. BMC Cardiovasc Disord, 10, 8.
DE SERRES, F. J. (2002) Worldwide racial and ethnic distribution of alpha1-antitrypsin deficiency: summary of an analysis of published genetic epidemiologic surveys. Chest, 122, 1818-29.
DE TORRES, J. P., MARIN, J. M., CASANOVA, C., COTE, C., CARRIZO, S., CORDOBA-LANUS, E., BAZ-DAVILA, R., ZULUETA, J. J., AGUIRRE-JAIME, A., SAETTA, M., COSIO, M. G. & CELLI, B. R. (2011) Lung cancer in patients with chronic obstructive pulmonary disease– incidence and predicting factors. Am J Respir Crit Care Med, 184, 913-9.
DEAN, M. M. (2008) End-of-life care for COPD patients. Prim Care Respir J, 17, 46-50.
DECRAMER, M., ANZUETO, A., KERWIN, E., KAELIN, T., RICHARD, N., CRATER, G., TABBERER, M., HARRIS, S. & CHURCH, A. 2014. Efficacy and safety of umeclidinium plus vilanterol versus tiotropium, vilanterol, or umeclidinium monotherapies over 24 weeks in patients with chronic obstructive pulmonary disease: results from two multicentre, blinded, randomised controlled trials. Lancet Respir Med, 2, 472-86.
DECRAMER, M., CELLI, B., KESTEN, S., LYSTIG, T., MEHRA, S. & TASHKIN, D. P. (2009) Effect of tiotropium on outcomes in patients with moderate chronic obstructive pulmonary disease (UPLIFT): a prespecified subgroup analysis of a randomised controlled trial. Lancet, 374, 1171-8.
DECRAMER, M., DE BENEDETTO, F., DEL PONTE, A. & MARINARI, S. (2005) Systemic effects of COPD. Respir Med, 99 Suppl B, S3-10.
DECRAMER, M., DE BOCK, V. & DOM, R. (1996) Functional and histologic picture of steroid-induced myopathy in chronic obstructive pulmonary disease. Am J Respir Crit Care Med, 153, 1958-64.
DECRAMER, M., LACQUET, L. M., FAGARD, R. & ROGIERS, P. (1994) Corticosteroids contribute to muscle weakness in chronic airflow obstruction. Am J Respir Crit Care Med, 150, 11-6.
DECRAMER, M. & STAS, K. J. (1992) Corticosteroid-induced myopathy involving respiratory muscles in patients with chronic obstructive pulmonary disease or asthma. Am Rev Respir Dis, 146, 800-2.
DECRAMER, M. L., CHAPMAN, K. R., DAHL, R., FRITH, P., DEVOUASSOUX, G., FRITSCHER, C., CAMERON, R., SHOAIB, M., LAWRENCE, D., YOUNG, D., MCBRYAN, D. & INVESTIGATORS, I. 2013. Once-daily indacaterol versus tiotropium for patients with severe chronic obstructive pulmonary disease (INVIGORATE): a randomised, blinded, parallel-group study. Lancet Respir Med, 1, 524-33
DESLEE, G., KLOOSTER, K., HETZEL, M., STANZEL, F., KESSLER, R., MARQUETTE, C. H., WITT, C., BLAAS, S., GESIERICH, W., HERTH, F. J., HETZEL, J., VAN RIKXOORT, E. M. & SLEBOS, D. J. 2014. Lung volume reduction coil treatment for patients with severe emphysema: a European multicentre trial. Thorax, 69, 980-6.
DI MARCO, F., VERGA, M., REGGENTE, M., MARIA CASANOVA, F., SANTUS, P., BLASI, F., ALLEGRA, L. & CENTANNI, S. (2006) Anxiety and depression in COPD patients: The roles of gender and disease severity. Respir Med, 100, 1767-74.
DIAZ-FUENTES, G., HASHMI, H. R. & VENKATRAM, S. 2016. Perioperative Evaluation of Patients with Pulmonary Conditions Undergoing Non-Cardiothoracic Surgery. Health Serv Insights, 9, 9-23.
DIAZ-GUZMAN, E., ARYAL, S. & MANNINO, D. M. (2012) Occupational chronic obstructive pulmonary disease: an update. Clin Chest Med, 33, 625-36.
DICKENS, C., KATON, W., BLAKEMORE, A., KHARA, A., TOMENSON, B., WOODCOCK, A., FRYER, A. & GUTHRIE, E. 2014. Complex interventions that reduce urgent care use in COPD: a systematic review with meta-regression. Respir Med, 108, 426-37.
DIJK, W. D., BEMT, L., HAAK-RONGEN, S., BISCHOFF, E., WEEL, C., VEEN, J. C. & SCHERMER, T. R. (2011) Multidimensional prognostic indices for use in COPD patient care. A systematic review. Respir Res, 12, 151.
DISANTOSTEFANO, R. L., LI, H., HINDS, D., GALKIN, D. V. & RUBIN, D. B. 2014. Risk of pneumonia with inhaled corticosteroid/long-acting beta2 agonist therapy in chronic obstructive pulmonary disease: a cluster analysis. Int J Chron Obstruct Pulmon Dis, 9, 457-68.
DOBLER, C. C., WONG, K. K. & MARKS, G. B. (2009) Associations between statins and COPD: a systematic review. BMC Pulm Med, 9, 32.
DODD, J. W., CHARLTON, R. A., VAN DEN BROEK, M. D. & JONES, P. W. 2013. Cognitive dysfunction in patients hospitalized with acute exacerbation of COPD. Chest, 144, 119-27.
DONAIRE-GONZALEZ, D., GIMENO-SANTOS, E., BALCELLS, E., DE BATLLE, J., RAMON, M. A., RODRIGUEZ, E., FARRERO, E., BENET, M., GUERRA, S., SAULEDA, J., FERRER, A., FERRER, J., BARBERA, J. A., RODRIGUEZ-ROISIN, R., GEA, J., AGUSTI, A., ANTO, J. M., GARCIA-AYMERICH, J. & GROUP, P.-C. S. 2015. Benefits of physical activity on COPD hospitalisation depend on intensity. Eur Respir J, 46, 1281-9.
DONALDSON, G. C., HURST, J. R., SMITH, C. J., HUBBARD, R. B. & WEDZICHA, J. A. (2010) Increased risk of myocardial infarction and stroke following exacerbation of COPD. Chest, 137, 1091-7.
DONG, Y. H., CHANG, C. H., LIN WU, F. L., SHEN, L. J., CALVERLEY, P. M., LOFDAHL, C. G., LAI, M. S. & MAHLER, D. A. 2014. Use of inhaled corticosteroids in patients with COPD and the risk of TB and influenza: A systematic review and meta-analysis of randomized controlled trials. a systematic review and meta-analysis of randomized controlled trials. Chest, 145, 1286-97.
DONG, Y. H., LIN, H. H., SHAU, W. Y., WU, Y. C., CHANG, C. H. & LAI, M. S. (2013) Comparative safety of inhaled medications in patients with chronic obstructive pulmonary disease: systematic review and mixed treatment comparison meta-analysis of randomised controlled trials. Thorax, 68, 48-56.
DONOHUE, J. F., FOGARTY, C., LOTVALL, J., MAHLER, D. A., WORTH, H., YORGANCIOGLU, A., IQBAL, A., SWALES, J., OWEN, R., HIGGINS, M. & KRAMER, B. (2010) Once-daily bronchodilators for chronic obstructive pulmonary disease: indacaterol versus tiotropium. Am J Respir Crit Care Med, 182, 155-62.
DONOHUE, J. F., MALEKI-YAZDI, M. R., KILBRIDE, S., MEHTA, R., KALBERG, C. & CHURCH, A. 2013. Efficacy and safety of once-daily umeclidinium/vilanterol 62.5/25 mcg in COPD. Respir Med, 107, 1538-46.
DONOHUE, J. F., NIEWOEHNER, D., BROOKS, J., O’DELL, D. & CHURCH, A. 2014. Safety and tolerability of once-daily umeclidinium/vilanterol 125/25 mcg and umeclidinium 125 mcg in patients with chronic obstructive pulmonary disease: results from a 52-week, randomized, double-blind, placebo-controlled study. Respir Res, 15, 78.
DONOHUE, J. F., WORSLEY, S., ZHU, C. Q., HARDAKER, L. & CHURCH, A. 2015. Improvements in lung function with umeclidinium/vilanterol versus fluticasone propionate/salmeterol in patients with moderate-to-severe COPD and infrequent exacerbations. Respir Med, 109, 870-81.
DOWSON, C. A., TOWN, G. I., FRAMPTON, C. & MULDER, R. T. (2004) Psychopathology and illness beliefs influence COPD self-management. J Psychosom Res, 56, 333-40.
DRANSFIELD, M. T., BOURBEAU, J., JONES, P. W., HANANIA, N. A., MAHLER, D. A., VESTBO, J., WACHTEL, A., MARTINEZ, F. J., BARNHART, F., SANFORD, L., LETTIS, S., CRIM, C. & CALVERLEY, P. M. 2013. Once-daily inhaled fluticasone furoate and vilanterol versus vilanterol only for prevention of exacerbations of COPD: two replicate double-blind, parallel-group, randomised controlled trials. Lancet Respir Med, 1, 210-23.
DRANSFIELD, M. T., FELDMAN, G., KORENBLAT, P., LAFORCE, C. F., LOCANTORE, N., PISTOLESI, M., WATKINS, M. L., CRIM, C. & MARTINEZ, F. J. 2014. Efficacy and safety of once-daily fluticasone furoate/vilanterol (100/25 mcg) versus twice-daily fluticasone propionate/salmeterol (250/50 mcg) in COPD patients. Respir Med, 108, 1171-9.
DRANSFIELD, M. T., KUNISAKI, K. M., STRAND, M. J., ANZUETO, A., BHATT, S. P., BOWLER, R. P., CRINER, G. J., CURTIS, J. L., HANANIA, N. A., NATH, H., PUTCHA, N., ROARK, S. E., WAN, E. S., WASHKO, G. R., WELLS, J. M., WENDT, C. H. & MAKE, B. J. 2017. Acute Exacerbations and Lung Function Loss in Smokers with and without Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med, 195, 324-330.
DRETZKE, J., MOORE, D., DAVE, C., MUKHERJEE, R., PRICE, M. J., BAYLISS, S., WU, X., JORDAN, R. E. & TURNER, A. M. 2016. The effect of domiciliary noninvasive ventilation on clinical outcomes in stable and recently hospitalized patients with COPD: a systematic review and meta-analysis. Int J Chron Obstruct Pulmon Dis, 11, 2269-2286.
DU, Q., JIN, J., LIU, X. & SUN, Y. 2016. Bronchiectasis as a Comorbidity of Chronic Obstructive Pulmonary Disease: A Systematic Review and Meta-Analysis. PLoS One, 11, e0150532.
DUNSTAN, D. W., BARR, E. L., HEALY, G. N., SALMON, J., SHAW, J. E., BALKAU, B., MAGLIANO, D. J., CAMERON, A. J., ZIMMET, P. Z. & OWEN, N. 2010. Television viewing time and mortality: the Australian Diabetes, Obesity and Lifestyle Study (AusDiab). Circulation, 121, 384-91.
EDUARD, W., PEARCE, N. & DOUWES, J. 2009. Chronic bronchitis, COPD, and lung function in farmers: the role of biological agents. Chest, 136, 716-25.
EFFING, T., MONNINKHOF, E. M., VAN DER VALK, P. D., VAN DER PALEN, J., VAN HERWAARDEN, C. L., PARTIDGE, M. R., WALTERS, E. H. & ZIELHUIS, G. A. (2007) Self-management education for patients with chronic obstructive pulmonary disease. Cochrane Database Syst Rev, CD002990.
EISENBERG, M. J., FILION, K. B., YAVIN, D., BELISLE, P., MOTTILLO, S., JOSEPH, L., GERVAIS, A., O’LOUGHLIN, J., PARADIS, G., RINFRET, S. & PILOTE, L. 2008. Pharmacotherapies for smoking cessation: a meta-analysis of randomized controlled trials. CMAJ, 179, 135-44.
EISER, N., HARTE, R., SPIROS, K., PHILLIPS, C. & ISAAC, M. T. (2005) Effect of treating depression on quality-of-life and exercise tolerance in severe COPD. COPD, 2, 233-41.
EISNER, M. D., ANTHONISEN, N., COULTAS, D., KUENZLI, N., PEREZ-PADILLA, R., POSTMA, D., ROMIEU, I., SILVERMAN, E. K. & BALMES, J. R. (2010a) An official American Thoracic Society public policy statement: Novel risk factors and the global burden of chronic obstructive pulmonary disease. Am J Respir Crit Care Med, 182, 693-718.
EISNER, M. D., BLANC, P. D., YELIN, E. H., KATZ, P. P., SANCHEZ, G., IRIBARREN, C. & OMACHI, T. A. (2010b) Influence of anxiety on health outcomes in COPD. Thorax, 65, 229-34.
EKSTROM, M., FRANKLIN, K. A. & STROM, K. E. Increased relative mortality in women with severe oxygen-dependent COPD. Chest, 137, 31-6.
EKSTROM, M., NILSSON, F., ABERNETHY, A. A. & CURROW, D. C. 2015. Effects of opioids on breathlessness and exercise capacity in chronic obstructive pulmonary disease. A systematic review. Ann Am Thorac Soc, 12, 1079-92.
EL MOUSSAOUI, R., ROEDE, B. M., SPEELMAN, P., BRESSER, P., PRINS, J. M. & BOSSUYT, P. M. (2008) Short-course antibiotic treatment in acute exacerbations of chronic bronchitis and COPD: a meta-analysis of double-blind studies. Thorax, 63, 415-22.
ELBEHAIRY, A. F., GUENETTE, J. A., FAISAL, A., CIAVAGLIA, C. E., WEBB, K. A., JENSEN, D., RAMSOOK, A. H., NEDER, J. A., O’DONNELL, D. E. & CANADIAN RESPIRATORY RESEARCH, N. 2016. Mechanisms of exertional dyspnoea in symptomatic smokers without COPD. Eur Respir J, 48, 694-705.
EMTNER, M., PORSZASZ, J., BURNS, M., SOMFAY, A. & CASABURI, R. 2003. Benefits of supplemental oxygen in exercise training in nonhypoxemic chronic obstructive pulmonary disease patients. Am J Respir Crit Care Med, 168, 1034-42.
ERNST, P., GONZALEZ, A. V., BRASSARD, P. & SUISSA, S. (2007) Inhaled corticosteroid use in chronic obstructive pulmonary disease and the risk of hospitalization for pneumonia. Am J Respir Crit Care Med, 176, 162-6.
ESTEBAN, A., ANZUETO, A., ALIA, I., GORDO, F., APEZTEGUIA, C., PALIZAS, F., CIDE, D., GOLDWASER, R., SOTO, L., BUGEDO, G., RODRIGO, C., PIMENTEL, J., RAIMONDI, G. & TOBIN, M. J. (2000) How is mechanical ventilation employed in the intensive care unit? An international utilization review. Am J Respir Crit Care Med, 161, 1450-8.
ESTEBAN, C., QUINTANA, J. M., EGURROLA, M., MORAZA, J., ABURTO, M., PEREZ-IZQUIERDO, J., BASUALDO, L. V. & CAPELASTEGUI, A. (2009) Classifying the severity of COPD: are the new severity scales better than the old? Int J Tuberc Lung Dis, 13, 783-90.
EURICH, D. T., SADOWSKI, C. A., SIMPSON, S. H., MARRIE, T. J. & MAJUMDAR, S. R. 2010. Recurrent community-acquired pneumonia in patients starting acid-suppressing drugs. Am J Med, 123, 47-53.
EVANS, M., HAMMOND, M., WILSON, K., LYE, M. & COPELAND, J. (1997) Placebo-controlled treatment trial of depression in elderly physically ill patients. Int J Geriatr Psychiatry, 12, 817-24.
EVANS, R. A., SINGH, S. J., COLLIER, R., WILLIAMS, J. E. & MORGAN, M. D. (2009) Pulmonary rehabilitation is successful for COPD irrespective of MRC dyspnoea grade. Respir Med, 103, 1070-5.
FABBRI, L. M., CALVERLEY, P. M., IZQUIERDO-ALONSO, J. L., BUNDSCHUH, D. S., BROSE, M., MARTINEZ, F. J. & RABE, K. F. (2009) Roflumilast in moderate-to-severe chronic obstructive pulmonary disease treated with longacting bronchodilators: two randomised clinical trials. Lancet, 374, 695-703.
FALAGAS, M. E., AVGERI, S. G., MATTHAIOU, D. K., DIMOPOULOS, G. & SIEMPOS, II (2008) Short- versus long-duration antimicrobial treatment for exacerbations of chronic bronchitis: a meta-analysis. J Antimicrob Chemother, 62, 442-50.
FAN, V. S., GAZIANO, J. M., LEW, R., BOURBEAU, J., ADAMS, S. G., LEATHERMAN, S., THWIN, S. S., HUANG, G. D., ROBBINS, R., SRIRAM, P. S., SHARAFKHANEH, A., MADOR, M. J., SAROSI, G., PANOS, R. J., RASTOGI, P., WAGNER, T. H., MAZZUCA, S. A., SHANNON, C., COLLING, C., LIANG, M. H., STOLLER, J. K., FIORE, L. & NIEWOEHNER, D. E. (2012) A comprehensive care management program to prevent chronic obstructive pulmonary disease hospitalizations: a randomized, controlled trial. Ann Intern Med, 156, 673-83.
FANNING, M., MCKEAN, M., SEYMOUR, K., PILLANS, P. & SCOTT, I. 2014. Adherence to guideline-based antibiotic treatment for acute exacerbations of chronic obstructive pulmonary disease in an Australian tertiary hospital. Intern Med J, 44, 903-10.
FARNE, H. A. & CATES, C. J. 2015. Long-acting beta2-agonist in addition to tiotropium versus either tiotropium or long-acting beta2-agonist alone for chronic obstructive pulmonary disease. Cochrane Database Syst Rev, 10, CD008989.
FEARY, J. R., RODRIGUES, L. C., SMITH, C. J., HUBBARD, R. B. & GIBSON, J. E. (2010) Prevalence of major comorbidities in subjects with COPD and incidence of myocardial infarction and stroke: a comprehensive analysis using data from primary care. Thorax, 65, 956-62.
FELDMAN, G., MALTAIS, F., KHINDRI, S., VAHDATI-BOLOURI, M., CHURCH, A., FAHY, W. A. & TRIVEDI, R. 2016. A randomized, blinded study to evaluate the efficacy and safety of umeclidinium 62.5 mug compared with tiotropium 18 mug in patients with COPD. Int J Chron Obstruct Pulmon Dis, 11, 719-30.
FERGUSON, G. T., CALVERLEY, P. M., ANDERSON, J. A., JENKINS, C. R., JONES, P. W., WILLITS, L. R., YATES, J. C., VESTBO, J. & CELLI, B. (2009) Prevalence and progression of osteoporosis in patients with COPD: results from the TOwards a Revolution in COPD Health study. Chest, 136, 1456-65.
FERGUSON, G. T., FELDMAN, G. J., HOFBAUER, P., HAMILTON, A., ALLEN, L., KORDUCKI, L. & SACHS, P. 2014. Efficacy and safety of olodaterol once daily delivered via Respimat(R) in patients with GOLD 2-4 COPD: results from two replicate 48-week studies. Int J Chron Obstruct Pulmon Dis, 9, 629-45.
FERGUSON, G. T., KARPEL, J., BENNETT, N., CLERISME-BEATY, E., GRONKE, L., VOSS, F. & BUHL, R. 2017. Effect of tiotropium and olodaterol on symptoms and patient-reported outcomes in patients with COPD: results from four randomised, double-blind studies. NPJ Prim Care Respir Med, 27, 7.
FERNANDEZ, A., MUNOZ, J., DE LA CALLE, B., ALIA, I., EZPELETA, A., DE LA CAL, M. A. & REYES, A. (1994) Comparison of one versus two bronchodilators in ventilated COPD patients. Intensive Care Med, 20, 199-202.
FERREIRA, I. M., BROOKS, D., WHITE, J. & GOLDSTEIN, R. (2012) Nutritional supplementation for stable chronic obstructive pulmonary disease. Cochrane Database Syst Rev, 12, CD000998.
FESTIC, E., BANSAL, V., GUPTA, E. & SCANLON, P. D. 2016. Association of Inhaled Corticosteroids with Incident Pneumonia and Mortality in COPD Patients; Systematic Review and Meta-Analysis. COPD, 13, 312-26.
FIELDS, A. C. & DIVINO, C. M. 2016. Surgical outcomes in patients with chronic obstructive pulmonary disease undergoing abdominal operations: An analysis of 331,425 patients. Surgery, 159, 1210-1216.
FISHMAN, A., MARTINEZ, F., NAUNHEIM, K., PIANTADOSI, S., WISE, R., RIES, A., WEINMANN, G. & WOOD, D. E. (2003) A randomized trial comparing lung-volume-reduction surgery with medical therapy for severe emphysema. N Engl J Med, 348, 2059-73.
FISHMAN, A. P. (1994) Pulmonary rehabilitation research. Am J Respir Crit Care Med, 149, 825-33.
FLETCHER, C. & PETO, R. (1977) The natural history of chronic airflow obstruction. Br Med J, 1, 1645-8.
FLETCHER, C. M., CLIFTON M., FAIRBAIRN AS., FRY J., GILSON JC., HIGGINS ITT., MAIR A., PEMBERTON J., ROGAN JM., SMITH DH. & WOOD CH. (1960) Standardized questionnaires on respiratory symptoms. Br Med J, 2, 1665.
FRASER, J. F., SPOONER, A. J., DUNSTER, K. R., ANSTEY, C. M. & CORLEY, A. 2016. Nasal high flow oxygen therapy in patients with COPD reduces respiratory rate and tissue carbon dioxide while increasing tidal and end-expiratory lung volumes: a randomised crossover trial. Thorax, 71, 759-61.
FRAT, J. P., THILLE, A. W., MERCAT, A., GIRAULT, C., RAGOT, S., PERBET, S., PRAT, G., BOULAIN, T., MORAWIEC, E., COTTEREAU, A., DEVAQUET, J., NSEIR, S., RAZAZI, K., MIRA, J. P., ARGAUD, L., CHAKARIAN, J. C., RICARD, J. D., WITTEBOLE, X., CHEVALIER, S., HERBLAND, A., FARTOUKH, M., CONSTANTIN, J. M., TONNELIER, J. M., PIERROT, M., MATHONNET, A., BEDUNEAU, G., DELETAGE-METREAU, C., RICHARD, J. C., BROCHARD, L., ROBERT, R., GROUP, F. S. & NETWORK, R. 2015.
FRITH, P. A., THOMPSON, P. J., RATNAVADIVEL, R., CHANG, C. L., BREMNER, P., DAY, P., FRENZEL, C. & KURSTJENS, N. 2015. Glycopyrronium once-daily significantly improves lung function and health status when combined with salmeterol/fluticasone in patients with COPD: the GLISTEN study-a randomised controlled trial. Thorax, 70, 519-27.
FURLANETTO, K. C., DONARIA, L., SCHNEIDER, L. P., LOPES, J. R., RIBEIRO, M., FERNANDES, K. B., HERNANDES, N. A. & PITTA, F. 2017. Sedentary Behavior Is an Independent Predictor of Mortality in Subjects With COPD. Respir Care, 62, 579-587.
FURUMOTO, A., OHKUSA, Y., CHEN, M., KAWAKAMI, K., MASAKI, H., SUEYASU, Y., IWANAGA, T., AIZAWA, H., NAGATAKE, T. & OISHI, K. (2008) Additive effect of pneumococcal vaccine and influenza vaccine on acute exacerbation in patients with chronic lung disease. Vaccine, 26, 4284-9.
FUSCHILLO, S., MARTUCCI, M., DONNER, C. F. & BALZANO, G. (2012) Airway bacterial colonization: the missing link between COPD and cardiovascular events? Respir Med, 106, 915-23.
GAN, W. Q., MAN, S. F., POSTMA, D. S., CAMP, P. & SIN, D. D. (2006) Female smokers beyond the perimenopausal period are at increased risk of chronic obstructive pulmonary disease: a systematic review and meta-analysis. Respir Res, 7, 52.
GARBER, C. E., BLISSMER, B., DESCHENES, M. R., FRANKLIN, B. A., LAMONTE, M. J., LEE, I. M., NIEMAN, D. C., SWAIN, D. P. & AMERICAN COLLEGE OF SPORTS, M. 2011. American College of Sports Medicine position stand. Quantity and quality of exercise for developing and maintaining cardiorespiratory, musculoskeletal, and neuromotor fitness in apparently healthy adults: guidance for prescribing exercise. Med Sci Sports Exerc, 43, 1334-59.
GARCIA-AYMERICH, J., LANGE, P., BENET, M., SCHNOHR, P. & ANTO, J. M. (2006) Regular physical activity reduces hospital admission and mortality in chronic obstructive pulmonary disease: a population based cohort study. Thorax, 61, 772-8.
GARCIA-AYMERICH, J., SERRA, I., GOMEZ, F. P., FARRERO, E., BALCELLS, E., RODRIGUEZ, D. A., DE BATLLE, J., GIMENO, E., DONAIRE-GONZALEZ, D., OROZCO-LEVI, M., SAULEDA, J., GEA, J., RODRIGUEZ-ROISIN, R., ROCA, J., AGUSTI, A. G. & ANTO, J. M. (2009) Physical activity and clinical and functional status in COPD. Chest, 136, 62-70.
GARCIA RODRIGUEZ, L. A., RUIGOMEZ, A., MARTIN-MERINO, E., JOHANSSON, S. & WALLANDER, M. A. (2008) Relationship between gastroesophageal reflux disease and COPD in UK primary care. Chest, 134, 1223-30.
GEAKE, J. B., DABSCHECK, E. J., WOOD-BAKER, R. & CATES, C. J. 2015. Indacaterol, a once-daily beta2-agonist, versus twice-daily beta(2)-agonists or placebo for chronic obstructive pulmonary disease. Cochrane Database Syst Rev, 1, CD010139.
GEDDES, D., DAVIES, M., KOYAMA, H., HANSELL, D., PASTORINO, U., PEPPER, J., AGENT, P., CULLINAN, P., MACNEILL, S. J. & GOLDSTRAW, P. (2000) Effect of lung-volume-reduction surgery in patients with severe emphysema. N Engl J Med, 343, 239-45.
GEDDES, E. L., O’BRIEN, K., REID, W. D., BROOKS, D. & CROWE, J. 2008. Inspiratory muscle training in adults with chronic obstructive pulmonary disease: an update of a systematic review. Respir Med, 102, 1715-29.
GEELHOED, E. A., BRAMELD, K. J., HOLMAN, C. D. & THOMPSON, P. J. (2007) Readmission and survival following hospitalization for chronic obstructive pulmonary disease: long-term trends. Intern Med J, 37, 87-94.
GERBER, A., MOYNIHAN, C., KLIM, S., RITCHIE, P. & KELLY, A. M. 2016. Compliance with a COPD bundle of care in an Australian emergency department: A cohort study. Clin Respir J.
GERSHON, A. S., MECREDY, G. C., GUAN, J., VICTOR, J. C., GOLDSTEIN, R. & TO, T. 2015. Quantifying comorbidity in individuals with COPD: a population study. Eur Respir J, 45, 51-9.
GIARDINO, N. D., CURTIS, J. L., ANDREI, A. C., FAN, V. S., BENDITT, J. O., LYUBKIN, M., NAUNHEIM, K., CRINER, G., MAKE, B., WISE, R. A., MURRAY, S. K., FISHMAN, A. P., SCIURBA, F. C., LIBERZON, I. & MARTINEZ, F. J. (2010) Anxiety is associated with diminished exercise performance and quality of life in severe emphysema: a cross-sectional study. Respir Res, 11, 29.
GIBSON, P. G. & MCDONALD, V. M. 2015. Asthma-COPD overlap 2015: now we are six. Thorax, 70, 683-91.
GILBERT, D. N. 2011. Procalcitonin as a biomarker in respiratory tract infection. Clin Infect Dis, 52 Suppl 4, S346-50.
GIMENO-SANTOS, E., FREI, A., STEURER-STEY, C., DE BATLLE, J., RABINOVICH, R. A., RASTE, Y., HOPKINSON, N. S., POLKEY, M. I., VAN REMOORTEL, H., TROOSTERS, T., KULICH, K., KARLSSON, N., PUHAN, M. A. & GARCIA-AYMERICH, J. 2014. Determinants and outcomes of physical activity in patients with COPD: a systematic review. Thorax, 69, 731-9.
GLOBAL INITIATIVE FOR CHRONIC OBSTRUCTIVE LUNG DISEASE (GOLD) 2017. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease (Updated 2017). GOLD.
GOLD STANDARDS FRAMEWORK PROGRAMME (2005) Prognostic Indicator Paper Vs 2.25.
GORE, J. M., BROPHY, C. J. & GREENSTONE, M. A. (2000) How well do we care for patients with end stage chronic obstructive pulmonary disease (COPD)? A comparison of palliative care and quality of life in COPD and lung cancer. Thorax, 55, 1000-6.
GORECKA, D., GORZELAK, K., SLIWINSKI, P., TOBIASZ, M. & ZIELINSKI, J. (1997) Effect of long-term oxygen therapy on survival in patients with chronic obstructive pulmonary disease with moderate hypoxaemia. Thorax, 52, 674-9.
GOSSELINK, R., DE VOS, J., VAN DEN HEUVEL, S. P., SEGERS, J., DECRAMER, M. & KWAKKEL, G. (2011) Impact of inspiratory muscle training in patients with COPD: what is the evidence? Eur Respir J, 37, 416-25.
GØTZSCHE, P. C. & JOHANSEN, H. K. (2016) Intravenous alpha-1 antitrypsin augmentation therapy for treating patients with alpha-1 antitrypsin deficiency and lung disease. Cochrane Database Syst Rev, CD007851.
GOURLAY, S. G., STEAD, L. F. & BENOWITZ, N. L. (2004) Clonidine for smoking cessation. Cochrane Database Syst Rev, CD000058.
GRAAT-VERBOOM, L., WOUTERS, E. F., SMEENK, F. W., VAN DEN BORNE, B. E., LUNDE, R. & SPRUIT, M. A. (2009) Current status of research on osteoporosis in COPD: a systematic review. Eur Respir J, 34, 209-18.
GRANT, I., HEATON, R. K., MCSWEENY, A. J., ADAMS, K. M. & TIMMS, R. M. (1982) Neuropsychologic findings in hypoxemic chronic obstructive pulmonary disease. Arch Intern Med, 142, 1470-6.
GREGERSEN, T. L., GREEN, A., FRAUSING, E., RINGBAEK, T., BRONDUM, E. & SUPPLI ULRIK, C. 2016. Do telemedical interventions improve quality of life in patients with COPD? A systematic review. Int J Chron Obstruct Pulmon Dis, 11, 809-22.
GRIFFITHS, T. L., BURR, M. L., CAMPBELL, I. A., LEWIS-JENKINS, V., MULLINS, J., SHIELS, K., TURNER-LAWLOR, P. J., PAYNE, N., NEWCOMBE, R. G., IONESCU, A. A., THOMAS, J. & TUNBRIDGE, J. (2000) Results at 1 year of outpatient multidisciplinary pulmonary rehabilitation: a randomised controlled trial. Lancet, 355, 362-8.
GRIFFITHS, T. L., PHILLIPS, C. J., DAVIES, S., BURR, M. L. & CAMPBELL, I. A. (2001) Cost effectiveness of an outpatient multidisciplinary pulmonary rehabilitation programme. Thorax, 56, 779-84.
GROSS, N. J., PETTY, T. L., FRIEDMAN, M., SKORODIN, M. S., SILVERS, G. W. & DONOHUE, J. F. (1989) Dose response to ipratropium as a nebulized solution in patients with chronic obstructive pulmonary disease. A three-center study. Am Rev Respir Dis, 139, 1188-91.
GROSS, R. D., ATWOOD, C. W., JR., ROSS, S. B., OLSZEWSKI, J. W. & EICHHORN, K. A. (2009) The coordination of breathing and swallowing in chronic obstructive pulmonary disease. Am J Respir Crit Care Med, 179, 559-65.
GROSSMAN, J. M., GORDON, R., RANGANATH, V. K., DEAL, C., CAPLAN, L., CHEN, W., CURTIS, J. R., FURST, D. E., MCMAHON, M., PATKAR, N. M., VOLKMANN, E. & SAAG, K. G. (2010) American College of Rheumatology 2010 recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis. Arthritis Care Res (Hoboken), 62, 1515-26.
GUDMUNDSSON, G., GISLASON, T., JANSON, C., LINDBERG, E., HALLIN, R., ULRIK, C. S., BRONDUM, E., NIEMINEN, M. M., AINE, T. & BAKKE, P. (2005) Risk factors for rehospitalisation in COPD: role of health status, anxiety and depression. Eur Respir J, 26, 414-9.
GUDMUNDSSON, G., GISLASON, T., JANSON, C., LINDBERG, E., ULRIK, C. S., BRONDUM, E., NIEMINEN, M. M., AINE, T., HALLIN, R. & BAKKE, P. (2006) Depression, anxiety and health status after hospitalisation for COPD: A multicentre study in the Nordic countries. Respiratory Medicine, 100, 87-93.
GUERRA, S. 2009. Asthma and chronic obstructive pulmonary disease. Curr Opin Allergy Clin Immunol, 9, 409-16.
GUERRERO, M., CRISAFULLI, E., LIAPIKOU, A., HUERTA, A., GABARRUS, A., CHETTA, A., SOLER, N. & TORRES, A. 2016. Readmission for Acute Exacerbation within 30 Days of Discharge Is Associated with a Subsequent Progressive Increase in Mortality Risk in COPD Patients: A Long-Term Observational Study. PLoS One, 11, e0150737.
GUIRGUIS-BLAKE, J. M., SENGER, C. A., WEBBER, E. M., MULARSKI, R. A. & WHITLOCK, E. P. 2016. Screening for Chronic Obstructive Pulmonary Disease: Evidence Report and Systematic Review for the US Preventive Services Task Force. Jama, 315, 1378-93.
GULMEZ, S. E., HOLM, A., FREDERIKSEN, H., JENSEN, T. G., PEDERSEN, C. & HALLAS, J. 2007. Use of proton pump inhibitors and the risk of community-acquired pneumonia: a population-based case-control study. Arch Intern Med, 167, 950-5.
GUO, R., PITTLER, M. H. & ERNST, E. (2006) Herbal medicines for the treatment of COPD: a systematic review. Eur Respir J, 28, 330-8.
GUO, Y., ZHANG, T., WANG, Z., YU, F., XU, Q., GUO, W., WU, C. & HE, J. 2016. Body mass index and mortality in chronic obstructive pulmonary disease: A dose-response meta-analysis. Medicine (Baltimore), 95, e4225.
GUPTA, D., AGARWAL, R., AGGARWAL, A. N., MATURU, V. N., DHOORIA, S., PRASAD, K. T., SEHGAL, I. S., YENGE, L. B., JINDAL, A., SINGH, N., GHOSHAL, A. G., KHILNANI, G. C., SAMARIA, J. K., GAUR, S. N., BEHERA, D. & JINDAL, S. K. 2014. Guidelines for diagnosis and management of chronic obstructive pulmonary disease: joint recommendations of Indian Chest Society and National College of Chest Physicians (India). Indian J Chest Dis Allied Sci, 56 Spec No, 5-54.
GUPTA, H., RAMANAN, B., GUPTA, P. K., FANG, X., POLICH, A., MODRYKAMIEN, A., SCHULLER, D. & MORROW, L. E. 2013. Impact of COPD on postoperative outcomes: results from a national database. Chest, 143, 1599-606.
GUYATT, G. H., TOWNSEND, M., PUGSLEY, S. O., KELLER, J. L., SHORT, H. D., TAYLOR, D. W. & NEWHOUSE, M. T. (1987) Bronchodilators in chronic air-flow limitation. Effects on airway function, exercise capacity, and quality of life. Am Rev Respir Dis, 135, 1069-74.